These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10586212)

  • 1. Long-term immune recovery after CD34+ immunoselected and unselected peripheral blood progenitor cell transplantation: a case-control study.
    Laurenti L; Sica S; Sorà F; Piccirillo N; Ortu La Barbera E; Chiusolo P; Salutari P; Rumi C; Rutella S; Leone G
    Haematologica; 1999 Dec; 84(12):1100-3. PubMed ID: 10586212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications.
    Steingrimsdottir H; Gruber A; Björkholm M; Svensson A; Hansson M
    Haematologica; 2000 Aug; 85(8):832-8. PubMed ID: 10942930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation.
    Baron F; Schaaf-Lafontaine N; Humblet-Baron S; Meuris N; Castermans E; Baudoux E; Frère P; Bours V; Fillet G; Beguin Y
    Transplantation; 2003 Dec; 76(12):1705-13. PubMed ID: 14688520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of hematological and immunological function during long-term follow-up after peripheral blood stem cell transplantation.
    Laurenti L; Sica S; Salutari P; Rutella S; Serafini R; D'Onofrio G; Rumi C; Leone G
    Haematologica; 1998 Feb; 83(2):138-42. PubMed ID: 9549925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autografting of highly purified peripheral blood progenitor cells following myeloablative therapy in patients with lymphoma: a prospective study of the long-term effects on tumor eradication, reconstitution of hematopoiesis and immune recovery.
    Dreger P; Viehmann K; von Neuhoff N; Glaubitz T; Petzoldt O; Glass B; Uharek L; Rautenberg P; Suttorp M; Mills B; Mitsky P; Schmitz N
    Bone Marrow Transplant; 1999 Jul; 24(2):153-61. PubMed ID: 10455343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poor lymphocyte recovery following CD34-selected autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma.
    Diviné M; Boutolleau D; Delfau-Larue MH; Beaujean F; Jouault H; Reyes F; Kuentz M; Bensussan A; Farcet JP; Boumsell L
    Br J Haematol; 1999 May; 105(2):349-60. PubMed ID: 10233403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies.
    Cao TM; Kusnierz-Glaz C; Valone F; Stockerl-Goldstein KE; Hu WW; Johnston L; Blume KG; Strober S; Negrin RS
    Cancer; 2001 Jun; 91(12):2205-13. PubMed ID: 11413507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of purified autologous peripheral blood CD34+ cells with low T cell content using CliniMACS device--a local experience.
    Leong CF; Habsah A; Teh HS; Goh KY; Fadilah SA; Cheong SK
    Malays J Pathol; 2008 Jun; 30(1):31-6. PubMed ID: 19108409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preliminary assessment of immune reconstitution after autologous peripheral hematopoietic stem cell transplantation (AHSCT)].
    Huang HQ; Cai QC; Shi YX; Lin XB; Wei J; Guo Y; Pan ZH
    Ai Zheng; 2006 Aug; 25(8):1023-8. PubMed ID: 16965687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recovery of lymphocyte and dendritic cell subsets after autologous CD34+ cell transplantation.
    Galy A; Rudraraju S; Baynes R; Klein J
    Bone Marrow Transplant; 2000 Jun; 25(12):1249-55. PubMed ID: 10871729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up of patients with non-Hodgkin lymphoma following myeloablative therapy and autologous transplantation of CD34+-selected peripheral blood progenitor cells.
    Witzens-Harig M; Heilmann C; Hensel M; Kornacker M; Benner A; Haas R; Fruehauf S; Ho AD
    Stem Cells; 2007 Jan; 25(1):228-35. PubMed ID: 17204607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune reconstitution after purified autologous and allogeneic blood stem cell transplantation compared with unmanipulated bone marrow transplantation in children.
    Schwinger W; Weber-Mzell D; Zois B; Rojacher T; Benesch M; Lackner H; Dornbusch HJ; Sovinz P; Moser A; Lanzer G; Schauenstein K; Ofner P; Handgretinger R; Urban C
    Br J Haematol; 2006 Oct; 135(1):76-84. PubMed ID: 16925797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic peripheral blood stem cell transplantation with CD34+-cell selection and delayed T-cell add-back in adults. Results of a single center pilot study.
    Martino R; Martín-Henao G; Sureda A; Altés A; Canals C; Brunet S; Sierra J
    Haematologica; 2000 Nov; 85(11):1165-71. PubMed ID: 11064469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of two different methods for CD34+ selection and T cell depletion in peripheral blood stem cell grafts--our experiences with CellPro, E rosetting and CliniMACS technique.
    Poloucková A; Vodvárková A; Kobylka P; Hrubá A; Gasová Z; Marinov I; Fales I; Sedlácek P; Kozák T; Starý J
    Neoplasma; 2001; 48(5):374-81. PubMed ID: 11845982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Kinetic study on the variety of lymphocytes and CD34+ cell subsets during autologous peripheral blood stem cell transplantation].
    Han XH; Shi YK; He XH; Yang JL; Liu P
    Zhonghua Zhong Liu Za Zhi; 2003 Jan; 25(1):47-50. PubMed ID: 12678987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune reconstitution after allogeneic stem cell transplantation: the impact of stem cell source and graft-versus-host disease.
    Abrahamsen IW; Sømme S; Heldal D; Egeland T; Kvale D; Tjønnfjord GE
    Haematologica; 2005 Jan; 90(1):86-93. PubMed ID: 15642674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unrelated peripheral blood stem cell transplantation with 'megadoses' of purified CD34+ cells in three children with refractory severe aplastic anemia.
    Schwinger W; Urban C; Lackner H; Kerbl R; Benesch M; Dornbusch HJ; Sovinz P; Schauenstein K; Schumm M; Handgretinger R
    Bone Marrow Transplant; 2000 Mar; 25(5):513-7. PubMed ID: 10713628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective T cell regeneration following high-dose chemotherapy rescued with CD34+ cell enriched peripheral blood progenitor cells in children.
    Heitger A; Kern H; Mayerl D; Maurer K; Nachbaur D; Frühwirth M; Fink FM; Niederwieser D
    Bone Marrow Transplant; 1999 Feb; 23(4):347-53. PubMed ID: 10100578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reconstitution of T-cell repertoire after autologous stem cell transplantation: influence of CD34 selection and cytomegalovirus infection.
    Peggs KS; Verfuerth S; Pizzey A; Khan N; Moss P; Goldstone AH; Yong K; Mackinnon S
    Biol Blood Marrow Transplant; 2003 Mar; 9(3):198-205. PubMed ID: 12652471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic attributes of cytokine mobilized peripheral blood stem cells and recovery following transplantation.
    Talmadge JE; Reed EC; Kessinger A; Kuszynski CA; Perry GA; Gordy CL; Mills KC; Thomas ML; Pirruccello SJ; Letheby BA; Arneson MA; Jackson JD
    Bone Marrow Transplant; 1996 Jan; 17(1):101-9. PubMed ID: 8673041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.